CathWorks Announces Key Events for EuroPCR 2025
Comunicato Precedente
Comunicato Successivo
Educational Symposium
The FFRangio System will be available for hands-on demonstrations and peer-to-peer education during Meet the Expert sessions hosted by leading physicians in the Medtronic booth.
"Our co-promotion partnership with Medtronic has enabled the rapid growth in adoption and seamless integration of the FFRangio System in hundreds of catheterization labs around the globe. We are excited about the prominent presence of FFRangio at EuroPCR and we look forward to continuing to partner with the interventional cardiology community to make FFRangio the standard of care globally," said Ramin Mousavi, President and CEO of CathWorks.
ABOUT CATHWORKS
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. For more information on CathWorks, visit www.cath.works and follow @CathWorks on LinkedIn.
Investors:
Mike Feher
[email protected]
Media:
Sarita Monico
[email protected]
Photo - https://mma.prnewswire.com/media/2688659/CathWorks_announces_key_events_for_EuroPCR_2025.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cathworks-announces-key-events-for-europcr-2025-302457317.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




